ViroGates (Denmark) Executives
| VIRO Stock | 7.38 1.18 19.03% |
ViroGates employs about 10 people. The company is managed by 5 executives with a total tenure of roughly 24 years, averaging almost 4.0 years of service per executive, having 2.0 employees per reported executive. Analysis of ViroGates' management performance can provide insight into the firm performance.
| Thomas Krarup Insider VP Marketing |
| Mark Silva Insider Chief Officer |
ViroGates |
ViroGates Management Team Effectiveness
The company has return on total asset (ROA) of (0.3851) % which means that it has lost $0.3851 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6204) %, meaning that it generated substantial loss on money invested by shareholders. ViroGates' management efficiency ratios could be used to measure how well ViroGates manages its routine affairs as well as how well it operates its assets and liabilities.ViroGates Workforce Comparison
ViroGates AS is rated first in number of employees category among related companies. The total workforce of Medical Devices industry is at this time estimated at about 98,481. ViroGates adds roughly 10.0 in number of employees claiming only tiny portion of all equities under Medical Devices industry.
The company has Profit Margin (PM) of (1.13) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.27) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.27. ViroGates AS Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. ViroGates AS Price Series Summation is a cross summation of ViroGates price series and its benchmark/peer.
ViroGates Notable Stakeholders
A ViroGates stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ViroGates often face trade-offs trying to please all of them. ViroGates' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ViroGates' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Thomas Krarup | VP Marketing | Profile | |
| Mark Silva | Chief Officer | Profile | |
| Jakob Knudsen | Chief Officer | Profile | |
| Jesper EugenOlsen | CoFounder Officer | Profile | |
| May Dyvelkov | VP Accounting | Profile |
About ViroGates Management Performance
The success or failure of an entity such as ViroGates AS often depends on how effective the management is. ViroGates management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ViroGates management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ViroGates management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
The data published in ViroGates' official financial statements usually reflect ViroGates' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of ViroGates AS. For example, before you start analyzing numbers published by ViroGates accountants, it's critical to develop an understanding of what ViroGates' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of ViroGates' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ViroGates' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in ViroGates' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ViroGates AS. Please utilize our Beneish M Score to check the likelihood of ViroGates' management manipulating its earnings.
ViroGates Workforce Analysis
Traditionally, organizations such as ViroGates use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ViroGates within its industry.ViroGates Manpower Efficiency
Return on ViroGates Manpower
| Revenue Per Employee | 765.6K | |
| Revenue Per Executive | 1.5M | |
| Net Loss Per Employee | 1.8M | |
| Net Loss Per Executive | 3.5M |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ViroGates AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for ViroGates Stock analysis
When running ViroGates' price analysis, check to measure ViroGates' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ViroGates is operating at the current time. Most of ViroGates' value examination focuses on studying past and present price action to predict the probability of ViroGates' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ViroGates' price. Additionally, you may evaluate how the addition of ViroGates to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |